Profiel
Lei Fang is currently the Vice President at Lepu Biopharma Co., Ltd. and the General Manager at CtM Bio Co., Ltd. Prior to these roles, Dr. Fang worked as the Director of Research & Development at I-MAB Biopharma Co., Ltd. from 2016 to 2020.
Dr. Fang also served as a Director at Third Venture Biopharma (Nanjing) Co., Ltd. Dr. Fang holds a doctorate degree from the Chinese Academy of Sciences and an undergraduate degree from Hebei University, which was conferred in 2004.
Actieve functies van Lei Fang
| Bedrijven | Functie | Begin |
|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Corporate Officer/Principal | 10-12-2020 |
CtM Bio Co., Ltd. | Algemeen Directeur | - |
Eerdere bekende functies van Lei Fang
| Bedrijven | Functie | Einde |
|---|---|---|
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Hoofd Techniek/Wetenschap/O&O | 01-04-2020 |
Third Venture Biopharma (Nanjing) Co., Ltd. | Directeur/Bestuurslid | - |
Opleiding van Lei Fang
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Chinese Academy of Sciences
Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hebei University
Hebei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Health Technology |
Lepu Biopharma Co., Ltd.
Lepu Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
CtM Bio Co., Ltd. | |
Third Venture Biopharma (Nanjing) Co., Ltd. |
















